EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evidence of Site‐Specific Mucosal Autoantibody Secretion in Rheumatoid Arthritis

Veerle F A M Derksen iD, Klara Martinsson iD, Anouk G van Mourik iD, Carlijn A Wagenaar, René E M Toes, Wendy Walrabenstein iD, Daniel Sjöberg, Dirkjan van Schaardenburg, Tom W J Huizinga, Alf Kastbom iD, Anna Svärd, Diane van der Woude iD

Arthritis & Rheumatology · 2025-03 · 77 (3) · 272-282

DOI: 10.1002/art.43036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 18.11.2024. Verfasst von Veerle F A M Derksen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Autoantibodies, Intestinal Mucosa, Anti-Citrullinated Protein Antibodies. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for Clinical Research Dalarna, Reade Foundation, Uppsala University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Anti–citrullinated protein antibodies (ACPA) have been detected in sputum and saliva, indicating that anti–modified protein antibodies (AMPA) can be produced at mucosal sites in patients with rheumatoid arthritis (RA). However, the body's largest mucosal compartment, the gut, has not yet been examined. We therefore investigated the presence of several AMPA (ACPA, anti–carbamylated protein antibodies [anti‐CarP], and anti–acetylated protein antibodies [AAPA]) at different mucosal sites, including the intestinal tract.

Methods

Paired fecal/ileal wash, saliva, and serum samples of patients with RA and healthy volunteers were collected in two independent cohorts. Data involving feces were replicated in a third cohort. In these secretions, AMPA were analyzed using in‐house enzyme‐linked immunosorbent assay with unmodified peptides as control. In fecal samples, total IgA and anti– Escherichia coli IgA were measured.

Results

ACPA, anti‐CarP, and AAPA IgA were measurable in saliva of seropositive patients with RA (prevalence 9%–40%). No AMPA could be detected in feces. IgA was present because total IgA and anti– E. coli IgA were detectable in feces of ACPA‐positive patients with RA and healthy donors. Results were confirmed in another cohort using colonoscopically collected ileal wash samples.

Conclusion

Our study shows the presence of ACPA, anti‐CarP, and AAPA IgA in saliva of ACPA‐seropositive patients with RA. However, no AMPA could be detected in feces/ileal wash samples of these patients, although our assays were able to measure other antigen‐specific antibodies. These data suggest that mucosal autoantibody secretion may occur in the oral mucosa of patients with RA, whereas no evidence could be found for this process in the lower gastrointestinal tract.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAutoantibodiesIntestinal MucosaAnti-Citrullinated Protein AntibodiesHumansMaleFemaleMiddle AgedSalivaFecesAdultImmunoglobulin AAgedCase-Control StudiesIleum

Substanzen

AutoantibodiesImmunoglobulin AAnti-Citrullinated Protein Antibodies

Autor:innen und Institutionen

  • Leiden University Medical Center, Leiden, The Netherlands.
  • Linköping University, Linköping, Sweden.
  • Reade and Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands.
  • Uppsala University, Uppsala, Sweden, and Falun Hospital, Falun, Sweden.
  • Linköping University, Linköping, Sweden, and Uppsala University, Uppsala, Sweden.

ORCID-Profile: Veerle F A M Derksen, Klara Martinsson, Anouk G van Mourik, Wendy Walrabenstein, Alf Kastbom, Diane van der Woude

Förderung

  • Center for Clinical Research Dalarna
  • Reade Foundation
  • Uppsala University
  • Stichting Vermeer 14
  • W. M. de Hoop Stichting
  • Netherlands Organization for Health Research and Development
  • Dutch Research Council
  • W.M. de Hoop Stichting

Zitieren

APA

Derksen, V. F. A. M., Martinsson, K., van Mourik, A. G., Wagenaar, C. A., Toes, R. E. M., Walrabenstein, W., Sjöberg, D., van Schaardenburg, D., Huizinga, T. W. J., Kastbom, A., Svärd, A., & van der Woude, D. (2025). Evidence of Site‐Specific Mucosal Autoantibody Secretion in Rheumatoid Arthritis. Arthritis & Rheumatology, 77(3), 272-282. https://doi.org/10.1002/art.43036

Vancouver

Derksen VFAM, Martinsson K, van Mourik AG, Wagenaar CA, Toes REM, Walrabenstein W, et al. Evidence of Site‐Specific Mucosal Autoantibody Secretion in Rheumatoid Arthritis. Arthritis & Rheumatology. 2025;77(3):272-282. doi:10.1002/art.43036

BibTeX
@article{Derksen2025,
  author = {Derksen, Veerle F A M and Martinsson, Klara and van Mourik, Anouk G and Wagenaar, Carlijn A and Toes, René E M and Walrabenstein, Wendy and Sjöberg, Daniel and van Schaardenburg, Dirkjan and Huizinga, Tom W J and Kastbom, Alf and Svärd, Anna and van der Woude, Diane},
  title = {Evidence of Site‐Specific Mucosal Autoantibody Secretion in Rheumatoid Arthritis},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  volume = {77},
  number = {3},
  pages = {272--282},
  doi = {10.1002/art.43036}
}
Kostenlos starten →